Pre-Open Stock Movers 10/09: (XLNX) (HCA) (NXPI) Higher; (ASAN) (AMD) (GME) Lower (more...)

Today's Pre-Open Stock Movers

VivoPower International PLC (Nasdaq: VVPR) 57% HIGHER; announced that it has signed a definitive agreement to acquire a 51% shareholding in Tembo e-LV B.V. (Tembo).

Medigus Ltd. (NASDAQ: MDGS) 38% HIGHER; announced its entry into e-commerce business by signing a definitive agreement to acquire a controlling interest in Smart Repair Pro, Inc. and Purex, Inc., two data-driven e-commerce companies, operating on the Amazon Marketplace.

MicroVision, Inc. (NASDAQ: MVIS) 18% HIGHER; was a bullish SeekingAlpha article yesterday afternoon saying the company's LiDAR is worth $2B.

Xilinx (NASDAQ: XLNX) 16.6% HIGHER; Advanced Micro Devices, Inc. (NASDAQ: AMD) is in advanced talks to acquire Xilinx (NASDAQ: XLNX) for over $30 billion, the Wall Street Journal reported citing people familiar with the matter.

Extreme Networks, Inc. (Nasdaq: EXTR) 16% HIGHER; Based on better-than-expected preliminary results across our geographies and major market segments, Extreme now expects to report first quarter 2021 revenue of $233 to $236 million, up 9% sequentially at the midpoint from $215.5 million last quarter. As a result, we now expect a GAAP loss per share of ($0.11) to ($0.08), and a non-GAAP EPS of $0.05 to $0.08. This compares to initial first quarter guidance for revenue of $220 to $230 million, GAAP loss per share of ($0.14) to ($0.11) and Non-GAAP EPS of $0.01 to $0.04. We expect GAAP and Non-GAAP Gross Margin to be slightly better than original guidance, while we expect GAAP and Non-GAAP Operating Expenses to be in-line with Extreme's prior guidance. (*Consensus sees Q1 EPS of $0.02 on revenue of $223.6 million).

Selecta Biosciences, Inc. (NASDAQ: SELB) 13.5% HIGHER; Selecta Biosciences and IGAN Biosciences, Inc. today announced that they have entered into a Research License and Option agreement to study Selectas ImmTOR immune tolerance platform in combination with IGANs immunoglobulin A (IgA) protease for the treatment of IgA Nephropathy (IgAN). In advance of exercising its option to enter into an exclusive license agreement, Selecta will conduct preclinical research to evaluate the utility of the combination of ImmTOR and IGANs IgA protease.

GenMark Diagnostics (NASDAQ: GNMK) 8.4% HIGHER; Preliminary Q3 Revenue Tops Consensus

HCA Holdings (NYSE: HCA) 7.8% HIGHER; Prelim. Q3 Revenue Tops ConsensusOct 8, 2020 05:02 PM

FuelCell Energy (NASDAQ: FCEL) 6.3% HIGHER; announced, "selection by the U.S. Department of Energy’s Office of Energy Efficiency and Renewable Energy, in collaboration with the Office of Nuclear Energy, for an $8.0 million funding award to support the design and manufacture of a SureSource electrolysis platform capable of producing of hydrogen."

General Electric (NYSE: GE) 5.7% HIGHER; Goldman Sachs reinstates coverage on with a Buy rating and a price target of $10.00.

NXP Semiconductors (NASDAQ: NXPI) 5.7% HIGHER; Prelim. Q3 Revenue Tops Consensus

Rocket Cos Inc. (NYSE: RKT) 4.6% HIGHER; JPMorgan upgraded from Neutral to Overweight with a price target of $28.50.

Wayfair (NYSE: W) 2.5% HIGHER; William Blair upgraded Neutral to Outperform after a comprehensive analysis of the company's business showed there still room for growth.

Asana (NYSE: ASAN) 2.4% LOWER; Bernstein initiates coverage on with an Underperform rating and a price target of $19.00.

Advanced Micro Devices, Inc. (NASDAQ: AMD) 2.2% LOWER; is in advanced talks to acquire Xilinx (NASDAQ: XLNX) for over $30 billion, the Wall Street Journal reported citing people familiar with the matter.

GameStop Corp. (NYSE: GME) 2% LOWER; consolidates after 44% gain Thursday on Microsoft deal

Zoom Video (NASDAQ: ZM) 2% HIGHER; Mizuho Securities initiates coverage on with a Buy rating and a price target of $550.00.

Gilead Sciences, Inc. (NASDAQ: GILD) 1.9% HIGHER; Final data from Gilead Sciences Inc's antiviral drug remdesivir showed the treatment cut COVID-19 recovery time by five days compared with patients who got a placebo, one day faster than indicated in preliminary data, the company and researchers said on Thursday.

You May Also Be Interested In

• JPMorgan (JPM) Dealmakers Lipsky and Lee Leaving the Bank - Reuters
• DermTech (DMTK) to Explore Strategic Alternatives and Implement Restructuring Plan
• Microsoft (MSFT) to Avoid Formal EU Probe Over $13B OpenAI Deal - Bloomberg